Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Forte Biosciences, Inc. Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update August 14, 2024 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules May 17, 2024 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update May 13, 2024 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update March 18, 2024 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules December 01, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update November 13, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update August 14, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102 August 01, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules May 19, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update May 15, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update March 31, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Mr. David Gryska Appointed to Forte Biosciences Board of Directors January 12, 2023 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update November 14, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors November 14, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update August 15, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President June 07, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules June 07, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update May 16, 2022 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance September 02, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7 August 16, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules August 02, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules July 12, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules July 01, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update May 10, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update May 03, 2021 From Forte Biosciences, Inc. Via Business Wire Tickers FBRX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.